An article published in the December issue of Gastrointestinal Endoscopy says that more than one third of patients undergoing outpatient endoscopy are at high risk for obstructive sleep apnea, ...

Use of GLP-1s or glucose-dependent insulinotropic polypeptide agonists before upper endoscopy significantly increased the risk for residual gastric volume, according to data published in JAMA Internal ...

Endoscopies are among the most common procedures in the U.S. with millions performed each year. For providers to safely and ...

Please provide your email address to receive an email when new articles are posted on . Glucagon-like peptide-1 receptor agonists were associated with a higher risk for aspiration pneumonia after ...

The use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may lead to an increased risk for aspiration pneumonia after endoscopic procedures, according to a new large population-based study. In ...

People on GLP-1 receptor agonists (RAs) had a significantly higher risk of aspiration pneumonia after undergoing gastrointestinal endoscopy, researchers reported. Compared with 0.63% of non-users, ...

Patients on GLP-1 receptor agonists had a low risk of food retention when an esophagogastroduodenoscopy (EGD) was combined with a colonoscopy, a small retrospective study found. Among more than 200 ...

New research from Cedars-Sinai suggests people who are scheduled for certain medical procedures should stop taking popular weight loss drugs in the days or weeks prior to avoid complications.

A consensus on major and minor key performance indicators (KPIs) was established to improve the quality of upper gastrointestinal (GI) endoscopy and reduce post-endoscopy upper GI cancer. The adoption ...